3 Takeaways From Aurora Cannabis’s (TSX:ACB) Founder’s Massive Stock Sale

Could a massive sale of Aurora Cannabis stock by founder Terry Booth mean something to the marijuana firm’s investors?

| More on:
Two colleagues working on new global financial strategy plan using tablet and laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Aurora Cannabis’s (TSX:ACB)(NYSE:ACB) founder, director, and former CEO Terry Booth has made a massive sale of 12,161,900 shares on his Aurora Cannabis stock position on the open market over the past few days. Should investors read much into this corporate insider’s latest move?

Mr. Booth made four separate large sell transactions of millions of Aurora shares at stock prices ranging between $1.34 and $0.92. The transactions comprised two-thirds of his position in the company’s equity.

The company reported these latest developments way before market open on Monday. The founder had sold the largest block of shares (5,000,000) at a share price of $0.925 on the same day.

Aurora management says the sale transaction is in connection with a previously announced transition plan.

Should Mr. Booth be selling Aurora Cannabis stock right now?

Mr. Terry Booth announced his quick retirement from his CEO position early in February this year. The company announced a succession plan, which relegated him to the strategic advisor position while still maintaining a board seat.

Aurora announced massive asset writedowns and layoffs in February in an apparent strong-willed strategic change that is taking place at this once aggressively growing marijuana firm.

The company’s strategic focus has shifted from aggressive growth to cash flow preservation and a restrained organic growth path, which is a traditional cautionary approach that start-ups in nascent industries take when faced with a not-so-enthusiastic capital market, a weak balance sheet, and a slower-than-desired market demand growth.

It can be argued that the company no longer saw its founder as a good fit for its future strategy as it changed course. But the question is, does Mr. Booth still believe in his darling “baby’s” future at this time?

The founder’s sudden sale of Aurora Cannabis stock could be a significant show of disappointment in the business. It could show a low conviction in its new turnaround strategy, which the interim CEO described as “progressing as planned toward appropriate capital allocation, balance sheet strength, and profitability.”

Entrepreneurs naturally do this sometimes

I would describe Terry Booth as an entrepreneur. Sometimes, entrepreneurs don’t like losing control of their businesses. To some, entirely exiting an equity position is just part of the departure process when leaving a founded company’s leadership role.

That said, the former CEO still holds millions of shares in the company.

Mr. Booth still indirectly holds 3,246,267 shares, 7,251 common share rights, and over 2,548,878 Aurora stock options to his name.

Perhaps it’s just a retirement decision

Corporate insiders can sell stock for several strategic and personal financial reasons.

When retiring, some significant investment portfolio asset-allocation decisions should be made. These should be made urgently if one finds himself immediately going into retirement, like Terry Booth did last month.

Holding a large concentrated position in a cannabis stock that pays no dividends, and in a company that is going through a high-risk strategic refocus program while faced with severe liquidity challenges, is not a great idea at retirement. Financial advisors will be at pains to let one see the lifestyle and capital risk associated with such a position.

One approach is to reduce portfolio volatility by divesting the position and investing in more stable income-producing assets. Asset classes like bonds, REITs, GICs, and defensive dividend stocks can offer respectable income yields while diversifying portfolio risk.

Perhaps Mr Booth made a sound retirement decision in divesting from a cannabis position. Perhaps he was only re-deploying his nest egg, and investors shouldn’t read too much in the retired gentleman’s portfolio.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Paradza has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »